top of page

Mablink has been awarded the R2B Onco 2019 Trophy

With more than 700 participants last April 4th/5th, the Auvergne-Rhône-Alpes Cancer Research Forum is one of the most federating events. During this event took place the Research2Business (R2B) Oncology Meeting which, among other scientific and innovation-driven objectives, has awarded Mablink and 2 other DeepTech companies the R2B Onco 2019 Trophy for their breakthrough technology in oncology. This event took place with the kind participation of Puls@lys, Linksium, SATT Grand Centre and Lyonbiopôle.

Source: website of Canceropôle Lyon Auvergne Rhône-Alpes (CLARA)

bottom of page